With a brand-name pen, the device measures the dose for you. With most compounded GLP-1s, you do the measuring: vial, syringe, and conversion math included. That raises the stakes on getting your dose right every time.
A different dosing process
Brand-name GLP-1 medications generally come in pre-set or pre-calibrated pens built to limit dosing errors (see our guide on pen types and injection technique). Compounded semaglutide and other compounded GLP-1 products are often dispensed as a vial of liquid with a supply of syringes. You measure and draw up your own dose, which leaves more room for error than a pre-set pen.
Where compounding stands now
Compounded GLP-1s became common while brand-name semaglutide and tirzepatide were on the FDA's drug shortage list. The FDA declared the tirzepatide shortage resolved on December 19, 2024, and the semaglutide shortage resolved on February 21, 2025. After short grace periods that ended in 2025, pharmacies and outsourcing facilities can no longer routinely make copies of these approved drugs. A compounding pharmacy can still prepare a version for an individual patient when the prescriber documents a clinical reason it needs to differ from the approved product. So as of September 2026, compounded vials are no longer a routine stand-in for brand-name pens. Our guides on the compounding pharmacy debate and the FDA's 503B bulks-list proposal cover the policy side.
Why vial dosing is easier to get wrong
Drawing your own dose from a vial adds steps a pen handles for you. You have to read the syringe markings correctly, know your medication's concentration (which can differ between compounding pharmacies, while brand-name concentrations are standardized), and convert your prescribed dose into the right volume to draw. Our walkthrough on reading an insulin syringe: units, mL, and mg takes you through that math step by step.
This is a documented problem. In July 2024 the FDA issued an alert after reports of patients drawing five to 20 times their intended dose from compounded vials. A poison-center case series described patients who gave themselves 10-fold overdoses of compounded semaglutide, with nausea, vomiting and abdominal pain that lasted for days (Lambson et al., J Am Pharm Assoc, 2023, DOI (external link)). One analysis of FDA adverse-event reports from 2018 to 2024 pointed the other way on this narrow question: compounded GLP-1s had lower reporting odds than brand products for administration and dosing errors as they were coded (McCall et al., Expert Opin Drug Saf, 2025, DOI (external link)). Voluntary reports like these show what gets reported, not how often errors actually happen. Sourcing and grey-market risk are separate questions, covered in our guide on pharmacy sources for GLP-1 medications and the compounding debate above.
What to ask your compounding pharmacy
- The exact concentration of your vial (for example, mg per mL) and how that translates into the volume you need to draw for your prescribed dose.
- Clear written instructions for drawing up and giving your specific dose. A state-licensed 503A pharmacy or a 503B outsourcing facility (the only type held to federal GMP manufacturing standards) should give you these without being asked twice.
- Which syringe size and markings fit the precision your dose needs.
- Whether the concentration will stay the same from refill to refill. Compounded formulations can vary between pharmacies, and an FDA adverse-event analysis found compounded GLP-1s were reported more often than brand products for compounding and manufacturing problems (McCall et al., Expert Opin Drug Saf, 2025, DOI (external link)).
A habit worth keeping
If you use a vial and syringe, ask your pharmacist or your prescriber's office to watch you draw up a dose in person, at least the first time. It's the same advice as in our guide on pen technique, with higher stakes because of the extra calculation. After that, check your math against your prescribed dose before every injection instead of relying on memory.
Study findings above are attributed to their authors and were located via PubMed.
This article is for general education and is not medical advice. Decisions about your specific medication and dosing belong with your prescriber and pharmacist.